Article
Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk.
Human molecular genetics - 1 Jun 2011
Pearce Celeste Leigh, Doherty Jennifer A, Van Den Berg David J, Moysich Kirsten, Hsu Chris, Cushing-Haugen Kara L, Conti David V, Ramus Susan J, Gentry-Maharaj Aleksandra, Menon Usha, Gayther Simon A, Pharoah Paul D P, Song Honglin, Kjaer Susanne K, Hogdall Estrid, Hogdall Claus, Whittemore Alice S, McGuire Valerie, Sieh Weiva, Gronwald Jacek, Medrek Krzysztof, Jakubowska Anna, Lubinski Jan, Chenevix-Trench Georgia, Beesley Jonathan, Webb Penelope M, Berchuck Andrew, Schildkraut Joellen M, Iversen Edwin S, Moorman Patricia G, Edlund Christopher K, Stram Daniel O, Pike Malcolm C, Ness Roberta B, Rossing Mary Anne, Wu Anna H
Abstract excerpt
The insulin-like growth factor (IGF) signaling axis plays an important role in cancer biology. We hypothesized that genetic variation in this pathway may influence risk of ovarian cancer. A three-center study of non-Hispanic whites including 1880 control women, 1135 women with invasive epithelial ovarian cancer and 321 women with borderline epithelial ovarian tumors was carried out to test the association between...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
